Saxon Leslie A
Cardiac Electrophysiology Department, University of California, San Francisco 94143-1354, USA.
J Card Fail. 2002 Jun;8(3):161-6. doi: 10.1054/jcaf.2002.125555.
Recently completed studies have evaluated the role of the Implantable Cardioverter Defibrillator (ICD) in extending life in the letting of left ventricular dysfunction.
All major primary prevention ICD trials performed in the United States are reviewed.
Data to date supports the use of the ICD for primary prevention of sudden death in the setting of ischemic left ventricular dysfunction. Data is lacking in an advanced heart failure population and in patients with nonischemic cardiomyopathy.
最近完成的研究评估了植入式心脏复律除颤器（ICD）在左心室功能障碍患者延长生命方面的作用。
回顾了在美国进行的所有主要一级预防ICD试验。
迄今为止的数据支持在缺血性左心室功能障碍情况下使用ICD进行猝死的一级预防。在晚期心力衰竭人群和非缺血性心肌病患者中缺乏相关数据。
